SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ANTISENSE PHARMA GmbH Trabedersen Shows Good Safety, Tolerability and Promising Survival in Patients with Pancreatic Carcinoma, Malignant Melanoma and Colorectoral Carcinoma